First Deliveries of Noveko(TM) Antimicrobial Face Masks to Mexico

Noveko International Inc. ("the Company") is pleased to announce that it has made a first delivery to Mexico of about one million 3xEZ and 4xEZU antimicrobial face masks, representing the quantity of such masks in stock at the Terrebonne warehouse of Noveko Inc. ("Noveko"). These masks are sold through Artimedica, S.A. de C.V., a major Mexican distributor serving the government, hospitals and other healthcare establishments in Mexico. Additional deliveries are planned in the short term as supplies become available.

As a result of the recent surge in swine flu cases, many health organizations have issued recommendations regarding prevention methods to limit the airborne transmission of the swine flu virus.

Cantronic Systems Inc. Delivers Its FeverScan M3000D Camera System to El Salvador in an Effort to Combat the Possible Spread of Swine Flu

Fever screening of passengers will begin immediately

Cantronic Systems Inc., ("Cantronic" or the "Company") (TSX-V CTS ) announced today that it has delivered its state-of-the-art FeverScan M3000D dual vision thermal imaging camera system to El Salvador, at the request of the Salvadoran government. This fever scanning and monitoring system will be installed immediately at the San Salvador Comalapa International Airport in an effort to combat the possible spread of Swine flu.

Female Health Company Receives FDA Approval for FC2 Female Condom(R)

Lower Cost Female Condom Increases Access to Woman-Initiated Protection Against HIV/AIDS

The Female Health Company (NYSE Alternext: FHC) today announced approval from the U.S. Food and Drug Administration (FDA) for the company's FC2 Female Condom(R) (FC2), a woman-initiated barrier method that helps to protect against sexually transmitted infections (STIs), HIV/AIDS, and unintended pregnancy. FHC's lower-cost second generation female condom will now be available for purchase and distribution in the United States. FDA approval will also enable the United States Agency for International Development (USAID) to procure FC2 for distribution to global HIV/AIDS programs.

Competitive Technologies Receives FDA Authorization for Sales of Pain Therapy Medical Device

Competitive Technologies, Inc. (NYSE Alternext US: CTT) announced today that the US Federal Drug Administration (FDA) has issued a 501(k) letter of authorization allowing US sales of CTT's pain therapy medical device. The device is a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. The FDA authorization expands CTT's opportunities for sales in both the US and globally. CTT has exclusive worldwide rights to this patented device. The CTT device also has Medical Device CE certification from the European Union allowing sales throughout Europe and several other countries.